Eugenol; Exemption From the Requirement of a Tolerance, 56895-56898 [2022-20041]
Download as PDF
Federal Register / Vol. 87, No. 179 / Friday, September 16, 2022 / Rules and Regulations
is not a ‘‘major rule’’ as defined by 5
U.S.C. 804(2).
enforce its requirements. (See section
307(b)(2)).
Under section 307(b)(1) of the Clean
Air Act, petitions for judicial review of
this action must be filed in the United
States Court of Appeals for the
appropriate circuit by November 15,
2022. Filing a petition for
reconsideration by the Administrator of
this final rule does not affect the finality
of this action for the purposes of judicial
review nor does it extend the time
within which a petition for judicial
review may be filed, and shall not
postpone the effectiveness of such rule
or action. This action may not be
challenged later in proceedings to
List of Subjects in 40 CFR Part 52
56895
PART 52—APPROVAL AND
PROMULGATION OF
IMPLEMENTATION PLANS
1. The authority citation for part 52
continues to read as follows:
■
Environmental protection, Air
pollution control, Incorporation by
reference, Ozone, Volatile organic
compounds.
Authority: 42 U.S.C. 7401 et seq.
Subpart HH—New York
Authority: 42 U.S.C. 7401 et seq.
2. In § 52.1670, paragraph (c) is
amended in the table by revising the
entry for ‘‘Title 6, Part 235’’ to read as
follows:
■
Lisa Garcia,
Regional Administrator, Region 2.
For the reasons set forth in the
preamble, 40 CFR part 52 is amended as
follows:
§ 52.1670
*
Identification of plan.
*
*
(c) * * *
*
*
EPA-APPROVED NEW YORK STATE REGULATIONS AND LAWS
State citation
*
*
*
Title 6, Part 235 ...............
*
*
*
*
*
BILLING CODE 6560–50–P
40 CFR Part 180
[EPA–HQ–OPP–2018–0522; FRL–10130–01–
OCSPP]
Eugenol; Exemption From the
Requirement of a Tolerance
Environmental Protection
Agency (EPA).
ACTION: Final rule.
AGENCY:
khammond on DSKJM1Z7X2PROD with RULES
9/16/2022
This regulation establishes an
exemption from the requirement of a
tolerance for residues of eugenol (2methoxy-4-(-2-propenyl)phenol) in or
on all food commodities when used in
accordance with good agricultural
practices. SciReg, Inc., on behalf of Eden
Research PLC, submitted a petition to
EPA under the Federal Food, Drug, and
Cosmetic Act (FFDCA), requesting an
exemption from the requirement of a
tolerance. This regulation eliminates the
need to establish a maximum
permissible level for residues of eugenol
Jkt 256001
This regulation is effective
September 16, 2022. Objections and
requests for hearings must be received
on or before November 15, 2022 and
must be filed in accordance with the
instructions provided in 40 CFR part
178 (see also Unit I.C. of the
SUPPLEMENTARY INFORMATION).
ADDRESSES: The docket for this action,
identified by docket identification (ID)
number EPA–HQ–OPP–2018–0522, is
available at https://www.regulations.gov
or at the Office of Pesticide Programs
Regulatory Public Docket (OPP Docket)
in the Environmental Protection Agency
Docket Center (EPA/DC), West William
Jefferson Clinton Bldg., Rm. 3334, 1301
Constitution Ave. NW, Washington, DC
20460–0001. The Public Reading Room
is open from 8:30 a.m. to 4:30 p.m.,
Monday through Friday, excluding legal
holidays. The telephone number for the
Public Reading Room and the OPP
Docket is (202) 566–1744. For the latest
status information on EPA/DC services,
docket access, visit https://
www.epa.gov/dockets.
FOR FURTHER INFORMATION CONTACT:
Charles Smith, Biopesticides and
PO 00000
Frm 00031
Fmt 4700
Sfmt 4700
*
• EPA approval finalized at [insert Federal Register
citation].
*
DATES:
ENVIRONMENTAL PROTECTION
AGENCY
16:02 Sep 15, 2022
2/11/2021
*
when used in accordance with this
exemption.
*
SUMMARY:
Comments
*
*
[FR Doc. 2022–19831 Filed 9–15–22; 8:45 am]
VerDate Sep<11>2014
EPA
approval
date
*
Consumer Products .........
*
*
State
effective
date
Title/subject
*
*
Pollution Prevention Division (7511P),
Office of Pesticide Programs,
Environmental Protection Agency, 1200
Pennsylvania Ave. NW, Washington, DC
20460–0001; main telephone number:
(703) 305–7090; email address:
BPPDFRNotices@epa.gov.
SUPPLEMENTARY INFORMATION:
I. General Information
A. Does this action apply to me?
You may be potentially affected by
this action if you are an agricultural
producer, food manufacturer, or
pesticide manufacturer. The following
list of North American Industrial
Classification System (NAICS) codes is
not intended to be exhaustive, but rather
provides a guide to help readers
determine whether this document
applies to them. Potentially affected
entities may include:
• Crop production (NAICS code 111).
• Animal production (NAICS code
112).
• Food manufacturing (NAICS code
311).
• Pesticide manufacturing (NAICS
code 32532).
E:\FR\FM\16SER1.SGM
16SER1
56896
Federal Register / Vol. 87, No. 179 / Friday, September 16, 2022 / Rules and Regulations
B. How can I get electronic access to
other related information?
You may access a frequently updated
electronic version of 40 CFR part 180
through the Office of the Federal
Register’s e-CFR site at https://
www.ecfr.gov/current/title-40.
khammond on DSKJM1Z7X2PROD with RULES
C. How can I file an objection or hearing
request?
Under FFDCA section 408(g), 21
U.S.C. 346a(g), any person may file an
objection to any aspect of this regulation
and may also request a hearing on those
objections. You must file your objection
or request a hearing on this regulation
in accordance with the instructions
provided in 40 CFR part 178. To ensure
proper receipt by EPA, you must
identify docket ID number EPA–HQ–
OPP–2018–0522 in the subject line on
the first page of your submission. All
objections and requests for a hearing
must be in writing and must be received
by the Hearing Clerk on or before
November 15, 2022. Addresses for mail
and hand delivery of objections and
hearing requests are provided in 40 CFR
178.25(b).
In addition to filing an objection or
hearing request with the Hearing Clerk
as described in 40 CFR part 178, please
submit a copy of the filing (excluding
any Confidential Business Information
(CBI)) for inclusion in the public docket.
Information not marked confidential
pursuant to 40 CFR part 2 may be
disclosed publicly by EPA without prior
notice. Submit the non-CBI copy of your
objection or hearing request, identified
by docket ID number EPA–HQ–OPP–
2018–0522, by one of the following
methods:
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
online instructions for submitting
comments. Do not submit electronically
any information you consider to be CBI
or other information whose disclosure is
restricted by statute.
• Mail: OPP Docket, Environmental
Protection Agency Docket Center (EPA/
DC), (28221T), 1200 Pennsylvania Ave.
NW, Washington, DC 20460–0001.
• Hand Delivery: To make special
arrangements for hand delivery or
delivery of boxed information, please
follow the instructions at https://
www.epa.gov/dockets.
Additional instructions on
commenting or visiting the docket,
along with more information about
dockets generally, is available at https://
www.epa.gov/dockets.
II. Background and Statutory Findings
In the Federal Register of August 24,
2018 (83 FR 42818) (FRL–9982–37),
VerDate Sep<11>2014
16:02 Sep 15, 2022
Jkt 256001
EPA issued a document pursuant to
FFDCA section 408(d)(3), 21 U.S.C.
346a(d)(3), announcing the filing of a
pesticide tolerance petition (PP8F8681)
by Eden Research PLC, 6 Priory Ct.,
Priory Court Business Park, Poulton,
Cirencester, GL7 5JB, United Kingdom
(c/o SciReg, Inc., 12733 Director’s Loop,
Woodbridge, VA 22192). The petition
requested that 40 CFR part 180 be
amended by establishing an exemption
from the requirement of a tolerance for
residues of eugenol (2-methoxy-4-(-2propenyl)phenol) in or on raw
agricultural commodities and processed
foods when used in accordance with
good agricultural practices. That
document referenced a summary of the
petition prepared by the petitioner Eden
Research plc, c/o SciReg Inc., which is
available in the docket, https://
www.regulations.gov. There were no
substantive comments received in
response to the notice of filing.
III. Aggregate Risk Assessment and
Determination of Safety
Section 408(c)(2)(A)(i) of FFDCA
allows EPA to establish an exemption
from the requirement for a tolerance (the
legal limit for a pesticide chemical
residue in or on a food) only if EPA
determines that the exemption is ‘‘safe.’’
Section 408(c)(2)(A)(ii) of FFDCA
defines ‘‘safe’’ to mean that ‘‘there is a
reasonable certainty that no harm will
result from aggregate exposure to the
pesticide chemical residue, including
all anticipated dietary exposures and all
other exposures for which there is
reliable information.’’ This includes
exposure through drinking water and in
residential settings but does not include
occupational exposure. Pursuant to
FFDCA section 408(c)(2)(B), in
establishing or maintaining in effect an
exemption from the requirement of a
tolerance, EPA must take into account
the factors set forth in FFDCA section
408(b)(2)(C), which require EPA to give
special consideration to exposure of
infants and children to the pesticide
chemical residue in establishing a
tolerance and to ‘‘ensure that there is a
reasonable certainty that no harm will
result to infants and children from
aggregate exposure to the pesticide
chemical residue. . . .’’ Additionally,
FFDCA section 408(b)(2)(D) requires
that the Agency consider ‘‘available
information concerning the cumulative
effects of a particular pesticide’s
residues’’ and ‘‘other substances that
have a common mechanism of toxicity.’’
EPA establishes exemptions from the
requirement of a tolerance only in those
cases where it can be clearly
demonstrated that the risks from
aggregate exposure to pesticide
PO 00000
Frm 00032
Fmt 4700
Sfmt 4700
chemical residues under reasonably
foreseeable circumstances will pose no
harm to human health. If EPA is able to
determine that a tolerance is not
necessary to ensure that there is a
reasonable certainty that no harm will
result from aggregate exposure to the
pesticide chemical residue, an
exemption from the requirement of a
tolerance may be established.
Consistent with FFDCA section
408(c)(2)(A), and the factors specified in
FFDCA section 408(c)(2)(B), EPA has
reviewed the available scientific data
and other relevant information in
support of this action. EPA has
sufficient data to assess the hazards of
and to make a determination on
aggregate exposure for, including
exposure resulting from the exemption
established by this action. EPA’s
assessment of exposures and risks
associated with eugenol follows.
IV. Toxicological Profile
Eugenol is a naturally occurring allyl
chain-substituted guaiacol and a
member of the phenylpropanoid class of
chemicals. Eugenol is also the main
constituent of clove bud oil (80 to 90%)
and clove leaf oil (82 to 88%), and is
also found in cinnamon bark and leaves,
Tulsi leaves, turmeric, pepper, ginger,
oregano and thyme and various other
herbs. As such, eugenol has long been
part of the normal human diet. It is
currently approved by the U.S. Food
and Drug Administration (FDA) for use
as a food additive and generally
recognized as safe (GRAS) by the FDA
(21 CFR 184.1257).
In conducting its hazard assessment
for eugenol, EPA relied on data from the
open scientific literature which includes
(1) a 19-week dietary study in rates, (2)
a 13-week dietary study in rates, (3) five
prenatal developmental toxicity studies,
and (4) several mutagenicity studies. In
these data, no adverse effects were seen
at the highest dose test of 300 mg/kg/
day. For guideline studies, EPA
generally recommends testing at a limit
dose of 1000 mg/kg/day. However,
based on the data reviewed from the
open literature along with a body of
knowledge regarding eugenol such as its
low toxicity; rapid degradation into the
environment; natural occurrence and
widespread use in herbs and a part of
the human diet; EPA would not expect
to see adverse effects at higher doses.
With regard to the overall
toxicological profile of eugenol, the
active ingredient is of minimal toxicity.
Where data was not available on
eugenol for acute inhalation and
primary eye irritation toxicity, it was
provided on isoeugenol. Isoeugenol is
structurally and physiochemically
E:\FR\FM\16SER1.SGM
16SER1
khammond on DSKJM1Z7X2PROD with RULES
Federal Register / Vol. 87, No. 179 / Friday, September 16, 2022 / Rules and Regulations
similar to eugenol. Based on data
provided for eugenol and isoeugenol,
eugenol is of low acute oral toxicity
(Toxicity Category III) and inhalation
toxicity (Toxicity Category III). The
active ingredient shows moderate
dermal toxicity (Toxicity Category II). It
is a mild eye (Toxicity Category III), a
severe dermal irritant (Toxicity Category
II), and a weak dermal sensitizer.
With regard to subchronic toxicity,
developmental toxicity, reproductive
toxicity and mutagenicity data
requirements for the active ingredient
eugenol, all data requirements were
satisfied by a combination of guideline
and non-guideline studies, data waivers,
and citations to studies from the Agency
database as well as to the open
literature. For the 90-day oral data
requirement, data was provided on
isoeugenol. There were no adverse
subchronic effects for any oral or dermal
routes of exposure. Regarding
subchronic dermal and subchronic
inhalation, EPA granted waivers for
these data requirements based on weight
of evidence approach (WOE). Specific to
subchronic dermal, eugenol is the main
constituent of clove bud oil and clove
leaf oil. It is used extensively in
dentistry for its analgesic and antiinflammatory activities. In addition, the
dermal margin of exposure (MOE) is
based on a 300 mg/kg/day point of
departure (POD) range from 460–33,000.
This is well above the Agency’s Level of
Concern (LOC) of 100.
In terms of subchronic inhalation
toxicity, eugenol has low inhalation
toxicity. Eugenol is used in spray
perfumes up to a concentration of 10%,
in air fresheners up to 5%, and oil of
clove in massage products and perfumes
up to 30%. Despite its broad usage in
cosmetics and air fresheners, no or few
adverse incidents have been reported.
Lastly, the occupational handler
inhalation MOEs are more than ten
times the LOC of 100, ranging from
550,000 to 12,000,000.
In terms of mutagenicity, the active
ingredient was determined to be nonmutagenic, and no adverse effects were
identified relative to either
developmental toxicity or reproductive
toxicity.
In conclusion, there were no adverse
subchronic effects for any oral, dermal,
inhalation, or developmental routes of
exposure and as stated previously, EPA
has granted a waiver of these data
requirements based on a WOE approach
for the subchronic toxicity testing
considering all the available eugenol
hazard and exposure data. This WOE
approach includes the following
rationale:
VerDate Sep<11>2014
16:02 Sep 15, 2022
Jkt 256001
1. Exposure from all routes and in all
scenarios is considered to be negligible
due to the following reasons: (1) eugenol
is moderately volatile with a vapor
pressure of 2.7 Pa @25oC; volatilization
from both moist and dry soil surfaces is
expected due to thymol’s Henry’s Law
Constant of 1.92 x 10–6 atm-cu m/mol
and vapor pressure; eugenol is expected
to exist solely as a vapor in the ambient
atmosphere, which would be readily
degraded in the atmosphere by reaction
with photochemically-produced
hydroxyl radicals; the half-life for this
reaction in the air is estimated to be 5.9
hours; vapor phase eugenol is also
degraded in the atmosphere by reaction
with ozone, the half-life for this reaction
is estimated to be 23 hours; Eugenol also
absorbs UV light and therefore is likely
susceptible to direct photolysis by
sunlight; and (2) eugenol is expected to
readily biodegrade as demonstrated in
guideline ready biodegradability
studies.
2. Eugenol is naturally occurring and
has long been part of the normal human
diet. It is currently FDA-approved for
use as a food additive (21 CFR 175.105).
FDA also considers eugenol as GRAS
(21 CFR 184.1257). Eugenol is
commonly used in foods, air fresheners,
cosmetics, and perfumes.
3. Eugenol demonstrates low toxicity
throughout its toxicity database. No
adverse effects were observed to highest
dose tested (300 mg/kg/day) (exception
is one eugenol study with no-observedadverse-effect level (NOAEL) of 300 mg/
kg/day and lowest-observed-adverseeffect-level (LOAEL) of 625 mg/kg/day
based on decreased body weight) in the
eugenol toxicity database. The database
includes a 19-week dietary study in rats,
a 13-week dietary study in rats, five
prenatal developmental toxicity studies,
and several genotoxicity studies. Data
from the open literature indicates that
eugenol is rapidly metabolized as well
as rapidly excreted.
A. Toxicological Points of Departure/
Levels of Concern
Based on the toxicological profile,
EPA did not identify any toxicological
endpoints of concern for eugenol.
B. Exposure Assessment
1. Dietary exposure from food, feed
uses, and drinking water. Eugenol is
naturally occurring and has long been
part of the normal human diet. As part
of its qualitative risk assessment for
eugenol, the Agency considered the
potential for any additional dietary
exposure to residues of eugenol from its
proposed use as a fungicide and
nematicide on agricultural use sites.
EPA expects dietary (food and drinking
PO 00000
Frm 00033
Fmt 4700
Sfmt 4700
56897
water) exposures from the proposed use
of eugenol to be negligible due to its
short half-life and biodegradable nature.
A quantitative dietary exposure
assessment was not conducted since a
toxicological endpoint for risk
assessment was not identified.
2. Residential exposure. The term
‘‘residential exposure’’ is used in this
document to refer to non-occupational,
non-dietary exposure. Eugenol is not
proposed to be registered for any
pesticidal uses that would result in
residential exposure. Residential
exposure may occur from non-pesticidal
uses such as air fresheners, cosmetics,
and perfumes. However, a quantitative
residential exposure assessment was not
conducted since a toxicological
endpoint for risk assessment was not
identified.
3. Cumulative effects from substances
with a common mechanism of toxicity.
Section 408(b)(2)(D)(v) of FFDCA
requires that, when considering whether
to establish a tolerance exemption, the
Agency consider ‘‘available
information’’ concerning the cumulative
effects of a particular pesticide’s
residues and ‘‘other substances that
have a common mechanism of toxicity.’’
EPA has not found that eugenol shares
a common mechanism of toxicity with
any other substances, and eugenol does
not appear to produce a toxic metabolite
produced by other substances. For the
purposes of this tolerance action,
therefore, EPA has assumed eugenol
does not have a common mechanism of
toxicity with other substances. For
information regarding EPA’s efforts to
determine which chemicals have a
common mechanism of toxicity and to
evaluate the cumulative effects of such
chemicals, see EPA’s website at https://
www.epa.gov/pesticide-science-andassessing-pesticide-risks/cumulativeassessment-risk-pesticides.
C. Safety Factor for Infants and Children
FFDCA Section 408(b)(2)(C) provides
that EPA shall retain an additional
tenfold (10X) margin of safety for infants
and children in the case of threshold
effects to account for prenatal and
postnatal toxicity and the completeness
of the database on toxicity and exposure
unless EPA determines based on reliable
data that a different margin of safety
will be safe for infants and children.
This additional margin of safety is
commonly referred to as the Food
Quality Protection Act (FQPA) safety
factor. In applying this provision, EPA
either retains the default value of 10X,
or uses a different additional safety
factor when reliable data available to
EPA support the choice of a different
factor. The Agency has determined that
E:\FR\FM\16SER1.SGM
16SER1
56898
Federal Register / Vol. 87, No. 179 / Friday, September 16, 2022 / Rules and Regulations
a qualitative risk assessment rather than
a quantitative risk assessment would be
most appropriate for the proposed use
based on the toxicity profiles of eugenol
along with its long history of human
exposure. For this reason, a FQPA safety
factor is not required at this time. EPA
has concluded there are no toxicological
endpoints of concern for the U.S.
population, including infants and
children.
D. Aggregate Risks
Based on the available data and
information, EPA has concluded that a
qualitative aggregate risk assessment is
appropriate to support this action, and
that risks of concern are not anticipated
from aggregate exposure to eugenol.
This conclusion is based on the low
toxicity of eugenol, long history of
human exposure to eugenol via the
normal human diet and expected rapid
degradation of eugenol in the
environment.
A full explanation of the data upon
which EPA relied and its risk
assessment based on those data can be
found in the December 15, 2021,
document entitled ‘‘Risk Assessment for
FIFRA Section 3 Registrations of
Eugenol Technical Containing 99.62%
Eugenol as an Active Ingredient,
Mevalone, Containing 3.21% Eugenol as
an Active Ingredient. Tolerance
Exemption Petition for Eugenol’’. This
document, as well as other relevant
information, is available in the docket
for this action as described under
ADDRESSES.
V. Determination of Safety for U.S.
Population, Infants and Children
Based on the Agency’s assessment,
EPA concludes that there is reasonable
certainty that no harm will result to the
U.S. population, including infants and
children, from aggregate exposure to
residues of eugenol. Therefore, the
establishment of an exemption from the
requirement of a tolerance for residues
of eugenol (2-methoxy-4-(-2propenyl)phenol) in or on all food
commodities when used in accordance
with good agricultural practices is safe
under FFDCA section 408.
VI. Other Considerations
khammond on DSKJM1Z7X2PROD with RULES
Analytical Enforcement Methodology
An analytical method is not required
for enforcement purposes since the
Agency is establishing an exemption
from the requirement of a tolerance
without any numerical limitation.
VII. Conclusions
Therefore, an exemption from the
requirement of a tolerance is established
VerDate Sep<11>2014
16:02 Sep 15, 2022
Jkt 256001
for residues of eugenol (2-methoxy-4-(2-propenyl)phenol) in or on all food
commodities when used in accordance
with good agricultural practices.
VIII. Statutory and Executive Order
Reviews
This action establishes an exemption
from the requirement of a tolerance
under FFDCA section 408(d) in
response to a petition submitted to the
Agency. The Office of Management and
Budget (OMB) has exempted these types
of actions from review under Executive
Order 12866, entitled ‘‘Regulatory
Planning and Review’’ (58 FR 51735,
October 4, 1993). Because this action
has been exempted from review under
Executive Order 12866, this action is
not subject to Executive Order 13211,
entitled ‘‘Actions Concerning
Regulations That Significantly Affect
Energy Supply, Distribution, or Use’’ (66
FR 28355, May 22, 2001), or Executive
Order 13045, entitled ‘‘Protection of
Children from Environmental Health
Risks and Safety Risks’’ (62 FR 19885,
April 23, 1997). This action does not
contain any information collections
subject to OMB approval under the
Paperwork Reduction Act (PRA), 44
U.S.C. 3501 et seq., nor does it require
any special considerations under
Executive Order 12898, entitled
‘‘Federal Actions to Address
Environmental Justice in Minority
Populations and Low-Income
Populations’’ (59 FR 7629, February 16,
1994).
Since tolerances and exemptions that
are established on the basis of a petition
under FFDCA section 408(d), such as
the tolerance exemption in this final
rule, do not require the issuance of a
proposed rule, the requirements of the
Regulatory Flexibility Act (RFA) (5
U.S.C. 601 et seq.), do not apply. This
action directly regulates growers, food
processors, food handlers, and food
retailers, not States or Tribes, nor does
this action alter the relationships or
distribution of power and
responsibilities established by Congress
in the preemption provisions of FFDCA
section 408(n)(4). As such, the Agency
has determined that this action will not
have a substantial direct effect on States
or Tribal Governments, on the
relationship between the National
Government and the States or Tribal
Governments, or on the distribution of
power and responsibilities among the
various levels of government or between
the Federal Government and Indian
Tribes. Thus, the Agency has
determined that Executive Order 13132,
entitled ‘‘Federalism’’ (64 FR 43255,
August 10, 1999), and Executive Order
PO 00000
Frm 00034
Fmt 4700
Sfmt 4700
13175, entitled ‘‘Consultation and
Coordination with Indian Tribal
Governments’’ (65 FR 67249, November
9, 2000), do not apply to this action. In
addition, this action does not impose
any enforceable duty or contain any
unfunded mandate as described under
Title II of the Unfunded Mandates
Reform Act (UMRA) (2 U.S.C. 1501 et
seq.).
This action does not involve any
technical standards that would require
Agency consideration of voluntary
consensus standards pursuant to section
12(d) of the National Technology
Transfer and Advancement Act
(NTTAA) (15 U.S.C. 272 note).
IX. Congressional Review Act
Pursuant to the Congressional Review
Act (5 U.S.C. 801 et seq.), EPA will
submit a report containing this rule and
other required information to the U.S.
Senate, the U.S. House of
Representatives, and the Comptroller
General of the United States prior to
publication of the rule in the Federal
Register. This action is not a ‘‘major
rule’’ as defined by 5 U.S.C. 804(2).
List of Subjects in 40 CFR Part 180
Environmental protection,
Administrative practice and procedure,
Agricultural commodities, Pesticides
and pests, Reporting and recordkeeping
requirements.
Dated: September 12, 2022.
Edward Messina,
Director, Office of Pesticide Programs.
Therefore, for the reasons stated in the
preamble, EPA is amending 40 CFR
chapter I as follows:
PART 180—TOLERANCES AND
EXEMPTIONS FOR PESTICIDE
CHEMICAL RESIDUES IN FOOD
1. The authority citation for part 180
continues to read as follows:
■
Authority: 21 U.S.C. 321(q), 346a and 371.
2. Add § 180.1395 to subpart D to read
as follows:
■
§ 180.1395 Eugenol; exemption from the
requirement of a tolerance.
An exemption from the requirement
of a tolerance is established for eugenol
(2-methoxy-4-(-2-propenyl)phenol) in or
on all food commodities when used in
accordance with good agricultural
practices.
[FR Doc. 2022–20041 Filed 9–15–22; 8:45 am]
BILLING CODE 6560–50–P
E:\FR\FM\16SER1.SGM
16SER1
Agencies
[Federal Register Volume 87, Number 179 (Friday, September 16, 2022)]
[Rules and Regulations]
[Pages 56895-56898]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-20041]
-----------------------------------------------------------------------
ENVIRONMENTAL PROTECTION AGENCY
40 CFR Part 180
[EPA-HQ-OPP-2018-0522; FRL-10130-01-OCSPP]
Eugenol; Exemption From the Requirement of a Tolerance
AGENCY: Environmental Protection Agency (EPA).
ACTION: Final rule.
-----------------------------------------------------------------------
SUMMARY: This regulation establishes an exemption from the requirement
of a tolerance for residues of eugenol (2-methoxy-4-(-2-
propenyl)phenol) in or on all food commodities when used in accordance
with good agricultural practices. SciReg, Inc., on behalf of Eden
Research PLC, submitted a petition to EPA under the Federal Food, Drug,
and Cosmetic Act (FFDCA), requesting an exemption from the requirement
of a tolerance. This regulation eliminates the need to establish a
maximum permissible level for residues of eugenol when used in
accordance with this exemption.
DATES: This regulation is effective September 16, 2022. Objections and
requests for hearings must be received on or before November 15, 2022
and must be filed in accordance with the instructions provided in 40
CFR part 178 (see also Unit I.C. of the SUPPLEMENTARY INFORMATION).
ADDRESSES: The docket for this action, identified by docket
identification (ID) number EPA-HQ-OPP-2018-0522, is available at
https://www.regulations.gov or at the Office of Pesticide Programs
Regulatory Public Docket (OPP Docket) in the Environmental Protection
Agency Docket Center (EPA/DC), West William Jefferson Clinton Bldg.,
Rm. 3334, 1301 Constitution Ave. NW, Washington, DC 20460-0001. The
Public Reading Room is open from 8:30 a.m. to 4:30 p.m., Monday through
Friday, excluding legal holidays. The telephone number for the Public
Reading Room and the OPP Docket is (202) 566-1744. For the latest
status information on EPA/DC services, docket access, visit https://www.epa.gov/dockets.
FOR FURTHER INFORMATION CONTACT: Charles Smith, Biopesticides and
Pollution Prevention Division (7511P), Office of Pesticide Programs,
Environmental Protection Agency, 1200 Pennsylvania Ave. NW, Washington,
DC 20460-0001; main telephone number: (703) 305-7090; email address:
[email protected].
SUPPLEMENTARY INFORMATION:
I. General Information
A. Does this action apply to me?
You may be potentially affected by this action if you are an
agricultural producer, food manufacturer, or pesticide manufacturer.
The following list of North American Industrial Classification System
(NAICS) codes is not intended to be exhaustive, but rather provides a
guide to help readers determine whether this document applies to them.
Potentially affected entities may include:
Crop production (NAICS code 111).
Animal production (NAICS code 112).
Food manufacturing (NAICS code 311).
Pesticide manufacturing (NAICS code 32532).
[[Page 56896]]
B. How can I get electronic access to other related information?
You may access a frequently updated electronic version of 40 CFR
part 180 through the Office of the Federal Register's e-CFR site at
https://www.ecfr.gov/current/title-40.
C. How can I file an objection or hearing request?
Under FFDCA section 408(g), 21 U.S.C. 346a(g), any person may file
an objection to any aspect of this regulation and may also request a
hearing on those objections. You must file your objection or request a
hearing on this regulation in accordance with the instructions provided
in 40 CFR part 178. To ensure proper receipt by EPA, you must identify
docket ID number EPA-HQ-OPP-2018-0522 in the subject line on the first
page of your submission. All objections and requests for a hearing must
be in writing and must be received by the Hearing Clerk on or before
November 15, 2022. Addresses for mail and hand delivery of objections
and hearing requests are provided in 40 CFR 178.25(b).
In addition to filing an objection or hearing request with the
Hearing Clerk as described in 40 CFR part 178, please submit a copy of
the filing (excluding any Confidential Business Information (CBI)) for
inclusion in the public docket. Information not marked confidential
pursuant to 40 CFR part 2 may be disclosed publicly by EPA without
prior notice. Submit the non-CBI copy of your objection or hearing
request, identified by docket ID number EPA-HQ-OPP-2018-0522, by one of
the following methods:
Federal eRulemaking Portal: https://www.regulations.gov.
Follow the online instructions for submitting comments. Do not submit
electronically any information you consider to be CBI or other
information whose disclosure is restricted by statute.
Mail: OPP Docket, Environmental Protection Agency Docket
Center (EPA/DC), (28221T), 1200 Pennsylvania Ave. NW, Washington, DC
20460-0001.
Hand Delivery: To make special arrangements for hand
delivery or delivery of boxed information, please follow the
instructions at https://www.epa.gov/dockets.
Additional instructions on commenting or visiting the docket, along
with more information about dockets generally, is available at https://www.epa.gov/dockets.
II. Background and Statutory Findings
In the Federal Register of August 24, 2018 (83 FR 42818) (FRL-9982-
37), EPA issued a document pursuant to FFDCA section 408(d)(3), 21
U.S.C. 346a(d)(3), announcing the filing of a pesticide tolerance
petition (PP8F8681) by Eden Research PLC, 6 Priory Ct., Priory Court
Business Park, Poulton, Cirencester, GL7 5JB, United Kingdom (c/o
SciReg, Inc., 12733 Director's Loop, Woodbridge, VA 22192). The
petition requested that 40 CFR part 180 be amended by establishing an
exemption from the requirement of a tolerance for residues of eugenol
(2-methoxy-4-(-2-propenyl)phenol) in or on raw agricultural commodities
and processed foods when used in accordance with good agricultural
practices. That document referenced a summary of the petition prepared
by the petitioner Eden Research plc, c/o SciReg Inc., which is
available in the docket, https://www.regulations.gov. There were no
substantive comments received in response to the notice of filing.
III. Aggregate Risk Assessment and Determination of Safety
Section 408(c)(2)(A)(i) of FFDCA allows EPA to establish an
exemption from the requirement for a tolerance (the legal limit for a
pesticide chemical residue in or on a food) only if EPA determines that
the exemption is ``safe.'' Section 408(c)(2)(A)(ii) of FFDCA defines
``safe'' to mean that ``there is a reasonable certainty that no harm
will result from aggregate exposure to the pesticide chemical residue,
including all anticipated dietary exposures and all other exposures for
which there is reliable information.'' This includes exposure through
drinking water and in residential settings but does not include
occupational exposure. Pursuant to FFDCA section 408(c)(2)(B), in
establishing or maintaining in effect an exemption from the requirement
of a tolerance, EPA must take into account the factors set forth in
FFDCA section 408(b)(2)(C), which require EPA to give special
consideration to exposure of infants and children to the pesticide
chemical residue in establishing a tolerance and to ``ensure that there
is a reasonable certainty that no harm will result to infants and
children from aggregate exposure to the pesticide chemical residue. . .
.'' Additionally, FFDCA section 408(b)(2)(D) requires that the Agency
consider ``available information concerning the cumulative effects of a
particular pesticide's residues'' and ``other substances that have a
common mechanism of toxicity.''
EPA establishes exemptions from the requirement of a tolerance only
in those cases where it can be clearly demonstrated that the risks from
aggregate exposure to pesticide chemical residues under reasonably
foreseeable circumstances will pose no harm to human health. If EPA is
able to determine that a tolerance is not necessary to ensure that
there is a reasonable certainty that no harm will result from aggregate
exposure to the pesticide chemical residue, an exemption from the
requirement of a tolerance may be established.
Consistent with FFDCA section 408(c)(2)(A), and the factors
specified in FFDCA section 408(c)(2)(B), EPA has reviewed the available
scientific data and other relevant information in support of this
action. EPA has sufficient data to assess the hazards of and to make a
determination on aggregate exposure for, including exposure resulting
from the exemption established by this action. EPA's assessment of
exposures and risks associated with eugenol follows.
IV. Toxicological Profile
Eugenol is a naturally occurring allyl chain-substituted guaiacol
and a member of the phenylpropanoid class of chemicals. Eugenol is also
the main constituent of clove bud oil (80 to 90%) and clove leaf oil
(82 to 88%), and is also found in cinnamon bark and leaves, Tulsi
leaves, turmeric, pepper, ginger, oregano and thyme and various other
herbs. As such, eugenol has long been part of the normal human diet. It
is currently approved by the U.S. Food and Drug Administration (FDA)
for use as a food additive and generally recognized as safe (GRAS) by
the FDA (21 CFR 184.1257).
In conducting its hazard assessment for eugenol, EPA relied on data
from the open scientific literature which includes (1) a 19-week
dietary study in rates, (2) a 13-week dietary study in rates, (3) five
prenatal developmental toxicity studies, and (4) several mutagenicity
studies. In these data, no adverse effects were seen at the highest
dose test of 300 mg/kg/day. For guideline studies, EPA generally
recommends testing at a limit dose of 1000 mg/kg/day. However, based on
the data reviewed from the open literature along with a body of
knowledge regarding eugenol such as its low toxicity; rapid degradation
into the environment; natural occurrence and widespread use in herbs
and a part of the human diet; EPA would not expect to see adverse
effects at higher doses.
With regard to the overall toxicological profile of eugenol, the
active ingredient is of minimal toxicity. Where data was not available
on eugenol for acute inhalation and primary eye irritation toxicity, it
was provided on isoeugenol. Isoeugenol is structurally and
physiochemically
[[Page 56897]]
similar to eugenol. Based on data provided for eugenol and isoeugenol,
eugenol is of low acute oral toxicity (Toxicity Category III) and
inhalation toxicity (Toxicity Category III). The active ingredient
shows moderate dermal toxicity (Toxicity Category II). It is a mild eye
(Toxicity Category III), a severe dermal irritant (Toxicity Category
II), and a weak dermal sensitizer.
With regard to subchronic toxicity, developmental toxicity,
reproductive toxicity and mutagenicity data requirements for the active
ingredient eugenol, all data requirements were satisfied by a
combination of guideline and non-guideline studies, data waivers, and
citations to studies from the Agency database as well as to the open
literature. For the 90-day oral data requirement, data was provided on
isoeugenol. There were no adverse subchronic effects for any oral or
dermal routes of exposure. Regarding subchronic dermal and subchronic
inhalation, EPA granted waivers for these data requirements based on
weight of evidence approach (WOE). Specific to subchronic dermal,
eugenol is the main constituent of clove bud oil and clove leaf oil. It
is used extensively in dentistry for its analgesic and anti-
inflammatory activities. In addition, the dermal margin of exposure
(MOE) is based on a 300 mg/kg/day point of departure (POD) range from
460-33,000. This is well above the Agency's Level of Concern (LOC) of
100.
In terms of subchronic inhalation toxicity, eugenol has low
inhalation toxicity. Eugenol is used in spray perfumes up to a
concentration of 10%, in air fresheners up to 5%, and oil of clove in
massage products and perfumes up to 30%. Despite its broad usage in
cosmetics and air fresheners, no or few adverse incidents have been
reported. Lastly, the occupational handler inhalation MOEs are more
than ten times the LOC of 100, ranging from 550,000 to 12,000,000.
In terms of mutagenicity, the active ingredient was determined to
be non-mutagenic, and no adverse effects were identified relative to
either developmental toxicity or reproductive toxicity.
In conclusion, there were no adverse subchronic effects for any
oral, dermal, inhalation, or developmental routes of exposure and as
stated previously, EPA has granted a waiver of these data requirements
based on a WOE approach for the subchronic toxicity testing considering
all the available eugenol hazard and exposure data. This WOE approach
includes the following rationale:
1. Exposure from all routes and in all scenarios is considered to
be negligible due to the following reasons: (1) eugenol is moderately
volatile with a vapor pressure of 2.7 Pa @25oC; volatilization from
both moist and dry soil surfaces is expected due to thymol's Henry's
Law Constant of 1.92 x 10-6 atm-cu m/mol and vapor pressure; eugenol is
expected to exist solely as a vapor in the ambient atmosphere, which
would be readily degraded in the atmosphere by reaction with
photochemically-produced hydroxyl radicals; the half-life for this
reaction in the air is estimated to be 5.9 hours; vapor phase eugenol
is also degraded in the atmosphere by reaction with ozone, the half-
life for this reaction is estimated to be 23 hours; Eugenol also
absorbs UV light and therefore is likely susceptible to direct
photolysis by sunlight; and (2) eugenol is expected to readily
biodegrade as demonstrated in guideline ready biodegradability studies.
2. Eugenol is naturally occurring and has long been part of the
normal human diet. It is currently FDA-approved for use as a food
additive (21 CFR 175.105). FDA also considers eugenol as GRAS (21 CFR
184.1257). Eugenol is commonly used in foods, air fresheners,
cosmetics, and perfumes.
3. Eugenol demonstrates low toxicity throughout its toxicity
database. No adverse effects were observed to highest dose tested (300
mg/kg/day) (exception is one eugenol study with no-observed-adverse-
effect level (NOAEL) of 300 mg/kg/day and lowest-observed-adverse-
effect-level (LOAEL) of 625 mg/kg/day based on decreased body weight)
in the eugenol toxicity database. The database includes a 19-week
dietary study in rats, a 13-week dietary study in rats, five prenatal
developmental toxicity studies, and several genotoxicity studies. Data
from the open literature indicates that eugenol is rapidly metabolized
as well as rapidly excreted.
A. Toxicological Points of Departure/Levels of Concern
Based on the toxicological profile, EPA did not identify any
toxicological endpoints of concern for eugenol.
B. Exposure Assessment
1. Dietary exposure from food, feed uses, and drinking water.
Eugenol is naturally occurring and has long been part of the normal
human diet. As part of its qualitative risk assessment for eugenol, the
Agency considered the potential for any additional dietary exposure to
residues of eugenol from its proposed use as a fungicide and nematicide
on agricultural use sites. EPA expects dietary (food and drinking
water) exposures from the proposed use of eugenol to be negligible due
to its short half-life and biodegradable nature. A quantitative dietary
exposure assessment was not conducted since a toxicological endpoint
for risk assessment was not identified.
2. Residential exposure. The term ``residential exposure'' is used
in this document to refer to non-occupational, non-dietary exposure.
Eugenol is not proposed to be registered for any pesticidal uses that
would result in residential exposure. Residential exposure may occur
from non-pesticidal uses such as air fresheners, cosmetics, and
perfumes. However, a quantitative residential exposure assessment was
not conducted since a toxicological endpoint for risk assessment was
not identified.
3. Cumulative effects from substances with a common mechanism of
toxicity. Section 408(b)(2)(D)(v) of FFDCA requires that, when
considering whether to establish a tolerance exemption, the Agency
consider ``available information'' concerning the cumulative effects of
a particular pesticide's residues and ``other substances that have a
common mechanism of toxicity.'' EPA has not found that eugenol shares a
common mechanism of toxicity with any other substances, and eugenol
does not appear to produce a toxic metabolite produced by other
substances. For the purposes of this tolerance action, therefore, EPA
has assumed eugenol does not have a common mechanism of toxicity with
other substances. For information regarding EPA's efforts to determine
which chemicals have a common mechanism of toxicity and to evaluate the
cumulative effects of such chemicals, see EPA's website at https://www.epa.gov/pesticide-science-and-assessing-pesticide-risks/cumulative-assessment-risk-pesticides.
C. Safety Factor for Infants and Children
FFDCA Section 408(b)(2)(C) provides that EPA shall retain an
additional tenfold (10X) margin of safety for infants and children in
the case of threshold effects to account for prenatal and postnatal
toxicity and the completeness of the database on toxicity and exposure
unless EPA determines based on reliable data that a different margin of
safety will be safe for infants and children. This additional margin of
safety is commonly referred to as the Food Quality Protection Act
(FQPA) safety factor. In applying this provision, EPA either retains
the default value of 10X, or uses a different additional safety factor
when reliable data available to EPA support the choice of a different
factor. The Agency has determined that
[[Page 56898]]
a qualitative risk assessment rather than a quantitative risk
assessment would be most appropriate for the proposed use based on the
toxicity profiles of eugenol along with its long history of human
exposure. For this reason, a FQPA safety factor is not required at this
time. EPA has concluded there are no toxicological endpoints of concern
for the U.S. population, including infants and children.
D. Aggregate Risks
Based on the available data and information, EPA has concluded that
a qualitative aggregate risk assessment is appropriate to support this
action, and that risks of concern are not anticipated from aggregate
exposure to eugenol. This conclusion is based on the low toxicity of
eugenol, long history of human exposure to eugenol via the normal human
diet and expected rapid degradation of eugenol in the environment.
A full explanation of the data upon which EPA relied and its risk
assessment based on those data can be found in the December 15, 2021,
document entitled ``Risk Assessment for FIFRA Section 3 Registrations
of Eugenol Technical Containing 99.62% Eugenol as an Active Ingredient,
Mevalone, Containing 3.21% Eugenol as an Active Ingredient. Tolerance
Exemption Petition for Eugenol''. This document, as well as other
relevant information, is available in the docket for this action as
described under ADDRESSES.
V. Determination of Safety for U.S. Population, Infants and Children
Based on the Agency's assessment, EPA concludes that there is
reasonable certainty that no harm will result to the U.S. population,
including infants and children, from aggregate exposure to residues of
eugenol. Therefore, the establishment of an exemption from the
requirement of a tolerance for residues of eugenol (2-methoxy-4-(-2-
propenyl)phenol) in or on all food commodities when used in accordance
with good agricultural practices is safe under FFDCA section 408.
VI. Other Considerations
Analytical Enforcement Methodology
An analytical method is not required for enforcement purposes since
the Agency is establishing an exemption from the requirement of a
tolerance without any numerical limitation.
VII. Conclusions
Therefore, an exemption from the requirement of a tolerance is
established for residues of eugenol (2-methoxy-4-(-2-propenyl)phenol)
in or on all food commodities when used in accordance with good
agricultural practices.
VIII. Statutory and Executive Order Reviews
This action establishes an exemption from the requirement of a
tolerance under FFDCA section 408(d) in response to a petition
submitted to the Agency. The Office of Management and Budget (OMB) has
exempted these types of actions from review under Executive Order
12866, entitled ``Regulatory Planning and Review'' (58 FR 51735,
October 4, 1993). Because this action has been exempted from review
under Executive Order 12866, this action is not subject to Executive
Order 13211, entitled ``Actions Concerning Regulations That
Significantly Affect Energy Supply, Distribution, or Use'' (66 FR
28355, May 22, 2001), or Executive Order 13045, entitled ``Protection
of Children from Environmental Health Risks and Safety Risks'' (62 FR
19885, April 23, 1997). This action does not contain any information
collections subject to OMB approval under the Paperwork Reduction Act
(PRA), 44 U.S.C. 3501 et seq., nor does it require any special
considerations under Executive Order 12898, entitled ``Federal Actions
to Address Environmental Justice in Minority Populations and Low-Income
Populations'' (59 FR 7629, February 16, 1994).
Since tolerances and exemptions that are established on the basis
of a petition under FFDCA section 408(d), such as the tolerance
exemption in this final rule, do not require the issuance of a proposed
rule, the requirements of the Regulatory Flexibility Act (RFA) (5
U.S.C. 601 et seq.), do not apply. This action directly regulates
growers, food processors, food handlers, and food retailers, not States
or Tribes, nor does this action alter the relationships or distribution
of power and responsibilities established by Congress in the preemption
provisions of FFDCA section 408(n)(4). As such, the Agency has
determined that this action will not have a substantial direct effect
on States or Tribal Governments, on the relationship between the
National Government and the States or Tribal Governments, or on the
distribution of power and responsibilities among the various levels of
government or between the Federal Government and Indian Tribes. Thus,
the Agency has determined that Executive Order 13132, entitled
``Federalism'' (64 FR 43255, August 10, 1999), and Executive Order
13175, entitled ``Consultation and Coordination with Indian Tribal
Governments'' (65 FR 67249, November 9, 2000), do not apply to this
action. In addition, this action does not impose any enforceable duty
or contain any unfunded mandate as described under Title II of the
Unfunded Mandates Reform Act (UMRA) (2 U.S.C. 1501 et seq.).
This action does not involve any technical standards that would
require Agency consideration of voluntary consensus standards pursuant
to section 12(d) of the National Technology Transfer and Advancement
Act (NTTAA) (15 U.S.C. 272 note).
IX. Congressional Review Act
Pursuant to the Congressional Review Act (5 U.S.C. 801 et seq.),
EPA will submit a report containing this rule and other required
information to the U.S. Senate, the U.S. House of Representatives, and
the Comptroller General of the United States prior to publication of
the rule in the Federal Register. This action is not a ``major rule''
as defined by 5 U.S.C. 804(2).
List of Subjects in 40 CFR Part 180
Environmental protection, Administrative practice and procedure,
Agricultural commodities, Pesticides and pests, Reporting and
recordkeeping requirements.
Dated: September 12, 2022.
Edward Messina,
Director, Office of Pesticide Programs.
Therefore, for the reasons stated in the preamble, EPA is amending
40 CFR chapter I as follows:
PART 180--TOLERANCES AND EXEMPTIONS FOR PESTICIDE CHEMICAL RESIDUES
IN FOOD
0
1. The authority citation for part 180 continues to read as follows:
Authority: 21 U.S.C. 321(q), 346a and 371.
0
2. Add Sec. 180.1395 to subpart D to read as follows:
Sec. 180.1395 Eugenol; exemption from the requirement of a tolerance.
An exemption from the requirement of a tolerance is established for
eugenol (2-methoxy-4-(-2-propenyl)phenol) in or on all food commodities
when used in accordance with good agricultural practices.
[FR Doc. 2022-20041 Filed 9-15-22; 8:45 am]
BILLING CODE 6560-50-P